Skip to content

Home
IOncology
Infectious Desease Frontier
IHepatology
Hematology Frontier
Conference topics
Experts Interviews
Informations
Live Broadcasting
Logout

Connecting Medical Expertise through Media

Search for:

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Home
IOncology
Infectious Disease Frontier
International Hepatology
Hematology Frontier
Conference topics
Experts’ Interviews
Informations

Search for:

#LiverDiseases

Home » #LiverDiseases

AASLD 2024丨Dr. Hui Wang’s Team: Serum HBV RNA and HBcrAg as Predictors of Low-Level Viremia in CHB Patients Treated with Nucleos(t)ide Analogs

AASLD 2024丨Dr. Hui Wang’s Team: Serum HBV RNA and HBcrAg as Predictors of Low-Level Viremia in CHB Patients Treated with Nucleos(t)ide Analogs

Posted by

By Mourabit Halima 2024.12.23

At the 2024 Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Dr. Hui Wang’s team from the Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao…

Chinese Expertise at AASLD 2024: Dr. Huiguo Ding’s Team Advances Non-Invasive Differentiation of PSVD and Cirrhotic Portal Hypertension Using Machine

Chinese Expertise at AASLD 2024: Dr. Huiguo Ding’s Team Advances Non-Invasive Differentiation of PSVD and Cirrhotic Portal Hypertension Using Machine

Posted by

By Mourabit Halima 2024.11.21

From November 15–19, 2024, the American Association for the Study of Liver Diseases (AASLD) convened in San Diego, USA. A study led by Dr. Huiguo Ding’s team from the Beijing…

Recent Posts

ASCO China Voice | Zhenzhen Liu: HELEN Series Studies Presented at ASCO Advance Precision Treatment Strategies for Breast Cancer
ASCO China Voice | Xiaowei Qi: Pembrolizumab-Free Anthracycline-Sparing Neoadjuvant Regimen with Penpulimab, Taxane, and Carboplatin Demonstrates Promising Efficacy and Safety in Triple-Negative Breast Cancer
ASCO China Voice | Zhimin Shao and Zhonghua Wang’s Team: IRIS-A Study Demonstrates That Capecitabine Plus Trastuzumab Provides Effective, Low-Toxicity De-escalated Adjuvant Therapy for Stage IA HER2-Positive Breast Cancer
ASCO China Voice | Jiong Wu: PANKU-Breast02 Meets Both PFS and OS Primary Endpoints, with Iza-Bren Delivering a New Breakthrough for Previously Treated Advanced Triple-Negative Breast Cancer
ASCO China Voice | Professor Hui Xie: BMI May Serve as a Simple Stratification Marker for Trastuzumab Deruxtecan in Advanced Breast Cancer

Recent Comments

Archives

Categories

Artificial intelligence
Hematology Frontier
Infectious Disease Frontier
International Hepatology
IOncology
Live broadcasting
Uncategorized
UroStream

LinkedIn
Twitter
Mail

Related Media:

Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
Paris, France